Alnylam Pharmaceuticals Inc. (ALNY) Dipped -6.38% or -5.79 To Price $84.95 On Friday

Alnylam Pharmaceuticals Inc. (ALNY) dipped -6.38% or -5.79 to $84.95. It is near 297732 shares traded, which is 40.24% compare to the average total volume 739837. The market cap of ALNY is $9.03 billion. The year to date change is 18.34%. The 52 week price range is from $60.27 to $146.79. Price of ALNY have changed -0.75% during last week. It have changed 8.63% over last month, 22.13% over last 3 months, -2.80% over last 6 months and -35.82% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ALNY is 83.74. It is -1.42% below current price. The 200-day Moving Averages for ALNY is 88.82. It is 4.56% above current price. The 52-week High is 146.79. It is 72.80% from the current price. The 52-week Low is 60.27. It is -29.05% from current price.

There are some statistics of ALNY. It is has market cap $9.03 billion. The share outstanding is 106.26 million. The average volume is 739837. The percent of top 15 Institution holding is 140.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ALNY is -49.63%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ALNY is -42.67%.


Share this post